Ignite Creation Date:
2025-12-24 @ 4:58 PM
Ignite Modification Date:
2025-12-25 @ 9:47 PM
Study NCT ID:
NCT02042950
Status:
TERMINATED
Last Update Posted:
2019-05-01
First Post:
2014-01-21
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Phase II Study of Carfilzomib in the Treatment of Relapsed/Refractory Mantle Cell Lymphoma
Sponsor:
M.D. Anderson Cancer Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-07-14
Start Date Type:
ACTUAL
Primary Completion Date:
2017-12-20
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-12-20
Completion Date Type:
ACTUAL
First Submit Date:
2014-01-21
First Submit QC Date:
None
Study First Post Date:
2014-01-23
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2019-04-09
Results First Submit QC Date:
None
Results First Post Date:
2019-05-01
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-04-09
Last Update Post Date:
2019-05-01
Last Update Post Date Type:
ACTUAL